The Korean Journal of Gastroenterology (대한소화기학회지)

The Korean Society of Gastroenterology (대한소화기학회)
권호 표지
DOI QR코드

DOI QR Code

Surgical Treatment of Gastric Carcinoma

위암의 수술 치료

Hur, Hoon;Park, Cho-Hyun
허훈;박조현

  • Published : 20090800
⟨ Previous Next ⟩

Abstract

The gastric cancer is the most common cancer in Korea. The only treatment modality showing improved survival for gastric cancer is curative surgical resection, which comprises the resection of stomach, proper lymphadenectomy, and reconstruction. However, specific surgical procedures should be decided according to the location of the cancer, advancement of the tumor, and patients’ condition. Surgical treatment for gastric cancer has been developed toward two directions that are minimal invasive surgery for early gastric cancer and multi-disciplinary approach for advanced gastric cancer. Laparoscopic surgery for early gastric cancer has been accepted for minimally invasive surgery. Moreover, the advancement of diagnostic tools to assess biological aggressiveness of the tumor enables physicians to perform endoscopic resection or minimized resection for early gastric cancer. Recently, surgeons try to extend the application of laparoscopic gastric resection and D2 lymphadenectomy to advanced gastric cancer. However, technical and oncological evidences based on clinical trials should be filed up before adopting it as a standard therapy. In case of advanced gastric cancer, in addition to radical surgery, various treatment modalities including chemotherapy, radiation, and molecular target therapy also have been applied in many clinical trials. However, it should be stressed that a prerequisite for precise evaluation of the efficacy of these combined treatment modalities would be the standardization of surgical procedure.

Keywords

References

  1. Ferlay J, Bray F, Pisani P, DM P. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Press: Lyon, 2004.
  2. Kim JP. Current status of surgical treatment of gastric cancer. J Surg Oncol 2002;79:79-80. https://doi.org/10.1002/jso.10050
  3. Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer 2002;5:1-5.
  4. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996; 347:995-999. https://doi.org/10.1016/S0140-6736(96)90144-0
  5. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1998;1:10-24. https://doi.org/10.1007/PL00011681
  6. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999;79:1522-1530. https://doi.org/10.1038/sj.bjc.6690243
  7. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-748. https://doi.org/10.1016/S0140-6736(95)90637-1
  8. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymphnode dissection for gastric cancer. N Engl J Med 1999;340: 908-914. https://doi.org/10.1056/NEJM199903253401202
  9. Sasako M. Clinical trials of surgical treatment of malignant diseases. Int J Clin Oncol 2005;10:165-170. https://doi.org/10.1007/s10147-005-0486-9
  10. Degiuli M, Sasako M, Calgaro M, et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interimanalysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 2004;30:303-308. https://doi.org/10.1016/j.ejso.2003.11.020
  11. Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004;90:1727-1732. https://doi.org/10.1038/sj.bjc.6601761
  12. Degiuli M, Sasako M, Ponti A, Soldati T, Danese F, Calvo F. Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol 1998; 16:1490-1493. https://doi.org/10.1200/JCO.1998.16.4.1490
  13. Pacelli F, Doglietto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 1993;80:1153-1156. https://doi.org/10.1002/bjs.1800800930
  14. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 1993;80:1015-1018. https://doi.org/10.1002/bjs.1800800829
  15. Korenaga D, Baba H, Kakeji Y, et al. Comparison of R1 and R2 gastrectomy for gastric cancer in patients over 80 years of age. J Surg Oncol 1991;48:136-141. https://doi.org/10.1002/jso.2930480213
  16. Lee WJ, Lee WC, Houng SJ, et al. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan. World J Surg 1995;19:707-713. https://doi.org/10.1007/BF00295910
  17. Ikeguchi M, Oka S, Gomyo Y, Tsujitani S, Maeta M, Kaibara N. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer. Anticancer Res 2000;20:1285-1289.
  18. Onate-Ocana LF, Aiello-Crocifoglio V, Mondragon-Sanchez R, Ruiz-Molina JM. Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 2000;7:210-217. https://doi.org/10.1007/BF02523656
  19. Katai H, Sano T, Fukagawa T, Shinohara H, Sasako M. Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Br J Surg 2003; 90:850-853. https://doi.org/10.1002/bjs.4106
  20. Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery 1998;123: 127-130. https://doi.org/10.1016/S0039-6060(98)70248-X
  21. Buhl K, Schlag P, Herfarth C. Quality of life and functional results following different types of resection for gastric carcinoma. Eur J Surg Oncol 1990;16:404-409.
  22. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 1999;230:170-178. https://doi.org/10.1097/00000658-199908000-00006
  23. Bozzetti F, Bonfanti G, Bufalino R, et al. Adequacy of margins of resection in gastrectomy for cancer. Ann Surg 1982; 196:685-690. https://doi.org/10.1097/00000658-198212001-00012
  24. Papachristou DN, Fortner JG. Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol 1981;18:47-53. https://doi.org/10.1002/jso.2930180108
  25. Ishikawa M, Kitayama J, Kaizaki S, et al. Prospective randomized trial comparing Billroth I and Roux-en-Y procedures after distal gastrectomy for gastric carcinoma. World J Surg 2005;29:1415-1420. https://doi.org/10.1007/s00268-005-7830-0
  26. Chin AC, Espat NJ. Total gastrectomy: options for the restoration of gastrointestinal continuity. Lancet Oncol 2003;4: 271-276. https://doi.org/10.1016/S1470-2045(03)01073-8
  27. El Halabi HM, Lawrence W. Clinical results of various reconstructions employed after total gastrectomy. J Surg Oncol 2008;97:186-192. https://doi.org/10.1002/jso.20928
  28. Endo S, Nishida T, Nishikawa K, et al. Motility of the pouch correlates with quality of life after total gastrectomy. Surgery 2006;139:493-500. https://doi.org/10.1016/j.surg.2005.08.013
  29. Fujiwara Y, Kusunoki M, Nakagawa K, Tanaka T, Hatada T, Yamamura T. Evaluation of J-pouch reconstruction after total gastrectomy: rho-double tract vs. J-pouch double tract. Dig Surg 2000;17:475-481. https://doi.org/10.1159/000051943
  30. Kono K, Iizuka H, Sekikawa T, et al. Improved quality of life with jejunal pouch reconstruction after total gastrectomy. Am J Surg 2003;185:150-154. https://doi.org/10.1016/S0002-9610(02)01211-4
  31. Nakane Y, Okumura S, Akehira K, et al. Jejunal pouch reconstruction after total gastrectomy for cancer. A randomized controlled trial. Ann Surg 1995;222:27-35. https://doi.org/10.1097/00000658-199507000-00005
  32. Nomura E, Shinohara H, Mabuchi H, Sang-Woong L, Sonoda T, Tanigawa N. Postoperative evaluation of the jejunal pouch reconstruction following proximal and distal gastrectomy for cancer. Hepatogastroenterology 2004;51:1561-1566.
  33. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-425. https://doi.org/10.1007/BF01655804
  34. Sawai K, Takahashi T, Suzuki H. New trends in surgery for gastric cancer in Japan. J Surg Oncol 1994;56:221-226. https://doi.org/10.1002/jso.2930560404
  35. Yasuda K, Shiraishi N, Suematsu T, Yamaguchi K, Adachi Y, Kitano S. Rate of detection of lymph node metastasis is correlated with the depth of submucosal invasion in early stage gastric carcinoma. Cancer 1999;85:2119-2123. https://doi.org/10.1002/(SICI)1097-0142(19990515)85:10<2119::AID-CNCR4>3.0.CO;2-M
  36. An JY, Baik YH, Choi MG, Noh JH, Sohn TS, Kim S. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience. Ann Surg 2007;246:749-753. https://doi.org/10.1097/SLA.0b013e31811f3fb7
  37. Higashi H, Natsugoe S, Ishigami S, et al. Distribution of lymph node metastasis including micrometastasis in gastric cancer with submucosal invasion. World J Surg 2003;27: 455-459. https://doi.org/10.1007/s00268-002-6601-4
  38. Kunisaki C, Shimada H, Ono H, et al. Predictive factors for pancreatic fistula after pancreaticosplenectomy for advanced gastric cancer in the upper third of the stomach. J Gastrointest Surg 2006;10:132-137. https://doi.org/10.1016/j.gassur.2005.04.015
  39. Kurihara N, Kubota T, Otani Y, et al. Lymph node metastasis of early gastric cancer with submucosal invasion. Br J Surg 1998;85:835-839. https://doi.org/10.1046/j.1365-2168.1998.00743.x
  40. Lo SS, Wu CW, Chen JH, et al. Surgical results of early gastric cancer and proposing a treatment strategy. Ann Surg Oncol 2007;14:340-347. https://doi.org/10.1245/s10434-006-9077-x
  41. Park DJ, Lee HK, Lee HJ, et al. Lymph node metastasis in early gastric cancer with submucosal invasion: feasibility of minimally invasive surgery. World J Gastroenterol 2004;10: 3549-3552. https://doi.org/10.3748/wjg.v10.i24.3549
  42. Shimoyama S, Seto Y, Yasuda H, Kaminishi M. Wider indications for the local resection of gastric cancer by adjacent lymphadenectomy. J Surg Oncol 2000;75:157-164. https://doi.org/10.1002/1096-9098(200011)75:3<157::AID-JSO2>3.0.CO;2-3
  43. Song KY, Hyung WJ, Kim HH, et al. Is gastrectomy mandatory for all residual or recurrent gastric cancer following endoscopic resection? A large-scale Korean multi-center study. J Surg Oncol 2008;98:6-10. https://doi.org/10.1002/jso.21074
  44. Ryu KW, Choi IJ, Doh YW, et al. Surgical indication for non-curative endoscopic resection in early gastric cancer. Ann Surg Oncol 2007;14:3428-3434. https://doi.org/10.1245/s10434-007-9536-z
  45. Hiki N, Kaminishi M. Pylorus-preserving gastrectomy in gastric cancer surgery--open and laparoscopic approaches. Langenbecks Arch Surg 2005;390:442-447. https://doi.org/10.1007/s00423-005-0573-4
  46. Shibata C, Shiiba KI, Funayama Y, et al. Outcomes after pylorus- preserving gastrectomy for early gastric cancer: a prospective multicenter trial. World J Surg 2004;28:857-861. https://doi.org/10.1007/s00268-004-7369-5
  47. Imada T, Rino Y, Takahashi M, et al. Postoperative functional evaluation of pylorus-preserving gastrectomy for early gastric cancer compared with conventional distal gastrectomy. Surgery 1998;123:165-170. https://doi.org/10.1016/S0039-6060(98)70254-5
  48. Nishikawa K, Kawahara H, Yumiba T, et al. Functional characteristics of the pylorus in patients undergoing pylorus-- preserving gastrectomy for early gastric cancer. Surgery 2002;131:613-624. https://doi.org/10.1067/msy.2002.124630
  49. Park DJ, Lee HJ, Jung HC, Kim WH, Lee KU, Yang HK. Clinical outcome of pylorus-preserving gastrectomy in gastric cancer in comparison with conventional distal gastrectomy with Billroth I anastomosis. World J Surg 2008;32:1029-1036. https://doi.org/10.1007/s00268-007-9441-4
  50. Furukawa H, Hiratsuka M, Imaoka S, et al. Phase II study of limited surgery for early gastric cancer: segmental gastric resection. Ann Surg Oncol 1999;6:166-170. https://doi.org/10.1007/s10434-999-0166-5
  51. Kobayashi T, Kazui T, Kimura T. Surgical local resection for early gastric cancer. Surg Laparosc Endosc Percutan Tech 2003;13:299-303.
  52. Ludwig K, Klautke G, Bernhard J, Weiner R. Minimally invasive and local treatment for mucosal early gastric cancer. Surg Endosc 2005;19:1362-1366. https://doi.org/10.1007/s00464-004-2249-5
  53. Nozaki I, Kubo Y, Kurita A, et al. Long-term outcome after laparoscopic wedge resection for early gastric cancer. Surg Endosc 2008;22:2665-2669. https://doi.org/10.1007/s00464-008-9795-1
  54. Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 1994;4:146-148.
  55. Hayashi H, Ochiai T, Shimada H, Gunji Y. Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer. Surg Endosc 2005;19:1172-1176. https://doi.org/10.1007/s00464-004-8207-4
  56. Huscher CG, Mingoli A, Sgarzini G, et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 2005;241:232-237. https://doi.org/10.1097/01.sla.0000151892.35922.f2
  57. Kitano S, Shiraishi N, Fujii K, Yasuda K, Inomata M, Adachi Y. A randomized controlled trial comparing openvs laparoscopy- assisted distal gastrectomy for the treatment of early gastric cancer: an interim report. Surgery 2002;131:S306-S311. https://doi.org/10.1067/msy.2002.120115
  58. Lee JH, Han HS. A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results. Surg Endosc 2005;19:168-173. https://doi.org/10.1007/s00464-004-8808-y
  59. Jeong O, Park YK. Intracorporeal circular stapling esophagojejunostomy using the transorally inserted anvil (OrVil) after laparoscopic total gastrectomy. Surg Endosc 2009, in press.
  60. Okabe H, Obama K, Tanaka E, et al. Intracorporeal esophagojejunal anastomosis after laparoscopic total gastrectomy for patients with gastric cancer. Surg Endosc 2008, in press.
  61. Okabe H, Satoh S, Inoue H, et al. Esophagojejunostomy through minilaparotomy after laparoscopic total gastrectomy. Gastric Cancer 2007;10:176-180. https://doi.org/10.1007/s10120-007-0432-9
  62. Okabe H, Satoh S, Inoue H, et al. Esophagojejunostomy through minilaparotomy after laparoscopic total gastrectomy. Gastric Cancer 2007;10:176-180. https://doi.org/10.1007/s10120-007-0432-9
  63. Usui S, Nagai K, Hiranuma S, Takiguchi N, Matsumoto A, Sanada K. Laparoscopy-assisted esophagoenteral anastomosis using endoscopic purse-string suture instrument “Endo-PSI (II)” and circular stapler. Gastric Cancer 2008;11:233-237. https://doi.org/10.1007/s10120-008-0481-8
  64. Hur H, Jeon HM, Kim W. Laparoscopic pancreas- and spleen-preserving D2 lymph node dissection in advanced (cT2) upper-third gastric cancer. J Surg Oncol 2008;97: 169-172. https://doi.org/10.1002/jso.20927
  65. Hyung WJ, Lim JS, Song J, Choi SH, Noh SH. Laparoscopic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. J Am Coll Surg 2008; 207:e6-11.
  66. Mochiki E, Toyomasu Y, Ogata K, et al. Laparoscopically assisted total gastrectomy with lymph node dissection for upper and middle gastric cancer. Surg Endosc 2008;22:1997-2002. https://doi.org/10.1007/s00464-008-0015-9
  67. Sakuramoto S, Kikuchi S, Futawatari N, et al. Laparoscopyassisted pancreas- and spleen-preserving total gastrectomy for gastric cancer as compared with open total gastrectomy. Surg Endosc 2009:[In print].
  68. Han HS, Kim YW, Yi NJ, Fleischer GD. Laparoscopy-assisted D2 subtotal gastrectomy in early gastric cancer. Surg Laparosc Endosc Percutan Tech 2003;13:361-365. https://doi.org/10.1097/00129689-200312000-00002
  69. Song KY, Kim SN, Park CH. Laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer: technical and oncologic aspects. Surg Endosc 2008;22: 655-659. https://doi.org/10.1007/s00464-007-9431-5
  70. Kawamura H, Homma S, Yokota R, et al. Inspection of safety and accuracy of D2 lymph node dissection in laparoscopy- assisted distal gastrectomy. World J Surg 2008;32: 2366-2370. https://doi.org/10.1007/s00268-008-9697-3
  71. Tokunaga M, Hiki N, Fukunaga T, et al. Laparoscopy-assisted distal gastrectomy with D2 lymph node dissection following standardization--a preliminary study. J Gastrointest Surg 2009;13:1058-1063. https://doi.org/10.1007/s11605-009-0840-8
  72. Uyama I, Sugioka A, Matsui H, Fujita J, Komori Y, Hasumi A. Laparoscopic D2 lymph node dissection for advanced gastric cancer located in the middle or lower third portion of the stomach. Gastric Cancer 2000;3:50-55. https://doi.org/10.1007/PL00011690
  73. Hur H, Jeon HM, Kim W. Laparoscopy-assisted distal gastrectomy with D2 lymphadenectomy for T2b advanced gastric cancers: three years' experience. J Surg Oncol 2008;98:515-519. https://doi.org/10.1002/jso.21155
  74. Huscher CG, Mingoli A, Sgarzini G, et al. Totally laparoscopic total and subtotal gastrectomy with extended lymph node dissection for early and advanced gastric cancer: early and long-term results of a 100-patient series. Am J Surg 2007;194:839-844. https://doi.org/10.1016/j.amjsurg.2007.08.037
  75. Hwang SI, Kim HO, Yoo CH, Shin JH, Son BH. Laparoscopic-assisted distal gastrectomy versus open distal gastrectomy for advanced gastric cancer. Surg Endosc 2009;23:1252-1258. https://doi.org/10.1007/s00464-008-0140-5
  76. Mingoli A, Sgarzini G, Binda B, et al. Totally laparoscopic approach for treatment of early and advanced gastric cancer. J Am Coll Surg 2007;204:187-188. https://doi.org/10.1016/j.jamcollsurg.2006.09.015
  77. Ziqiang W, Feng Q, Zhimin C, et al. Comparison of laparoscopically assisted and open radical distal gastrectomy with extended lymphadenectomy for gastric cancer management. Surg Endosc 2006;20:1738-1743. https://doi.org/10.1007/s00464-006-0031-6
  78. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 1997; 349:1668-1669.
  79. Hayashi H, Ochiai T, Mori M, et al. Sentinel lymph node mapping for gastric cancer using a dual procedure with dyeand gamma probe-guided techniques. J Am Coll Surg 2003; 196:68-74. https://doi.org/10.1016/S1072-7515(02)01594-6
  80. Hiratsuka M, Miyashiro I, Ishikawa O, et al. Application of sentinel node biopsy to gastric cancer surgery. Surgery 2001; 129:335-340. https://doi.org/10.1067/msy.2001.111699
  81. Kim MC, Kim HH, Jung GJ, et al. Lymphatic mapping and sentinel node biopsy using ${99m}Tc$ tin colloid in gastric cancer. Ann Surg 2004;239:383-387. https://doi.org/10.1097/01.sla.0000114227.70480.14
  82. Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y, Kitajima M. Radio-guided sentinel node detection for gastric cancer. Br J Surg 2002;89:604-608. https://doi.org/10.1046/j.1365-2168.2002.02065.x
  83. Nakahara T, Kitagawa Y, Yakeuchi H, et al. Preoperative lymphoscintigraphy for detection of sentinel lymph node in patients with gastric cancer--initial experience. Ann Surg Oncol 2008;15:1447-1453. https://doi.org/10.1245/s10434-008-9829-x
  84. Zulfikaroglu B, Koc M, Ozmen MM, Kucuk NO, Ozalp N, Aras G. Intraoperative lymphatic mapping and sentinel lymph node biopsy using radioactive tracer in gastric cancer. Surgery 2005;138:899-904. https://doi.org/10.1016/j.surg.2005.04.014
  85. Mikhail AA, Orvieto MA, Billatos ES, et al. Robotic-assisted laparoscopic prostatectomy: first 100 patients with one year of follow-up. Urology 2006;68:1275-1279. https://doi.org/10.1016/j.urology.2006.08.1060
  86. Rodriguez E, Kypson AP, Moten SC, Nifong LW, Chitwood WR. Robotic mitral surgery at East Carolina University: a 6 year experience. Int J Med Robot 2006;2:211-215. https://doi.org/10.1002/rcs.80
  87. Anderson C, Hellan M, Kernstine K, et al. Robotic surgery for gastrointestinal malignancies. Int J Med Robot 2007;3: 297-300. https://doi.org/10.1002/rcs.155
  88. Giulianotti PC, Coratti A, Angelini M, et al. Robotics in general surgery: personal experience in a large community hospital. Arch Surg 2003;138:777-784. https://doi.org/10.1001/archsurg.138.7.777
  89. Hashizume K, Tsukahara T, Yamada K, Koyama H, Ushida K. Megasphaera elsdenii JCM1772T normalizes hyperlactate production in the large intestine of fructooligosaccharide-fed rats by stimulating butyrate production. J Nutr 2003;133: 3187-3190. https://doi.org/10.1093/jn/133.10.3187
  90. Song J, Oh SJ, Kang WH, Hyung WJ, Choi SH, Noh SH. Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures. Ann Surg 2009;249:927-932. https://doi.org/10.1097/01.sla.0000351688.64999.73
  91. Yonemura Y, Wu CC, Fukushima N, et al. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. Hepatogastroenterology 2006;53: 389-394.
  92. Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Szczepanik A. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 2007;193: 10-15. https://doi.org/10.1016/j.amjsurg.2006.04.018
  93. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang- Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 2004;91:283-287. https://doi.org/10.1002/bjs.4433
  94. Wu CW, Hsiung CA, Lo SS, et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 2006;7:309-315. https://doi.org/10.1016/S1470-2045(06)70623-4
  95. Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. J Clin Oncol 2004;22:2767-2773. https://doi.org/10.1200/JCO.2004.10.184
  96. Kodera Y, Sasako M, Yamamoto S, Sano T, Nashimoto A, Kurita A. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 2005;92:1103-1109. https://doi.org/10.1002/bjs.4979
  97. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008;359:453-462. https://doi.org/10.1056/NEJMoa0707035
  98. Brady MS, Rogatko A, Dent LL, Shiu MH. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 1991;126:359-364. https://doi.org/10.1016/S0002-9610(73)80125-4
  99. Kwon SJ. Prognostic impact of splenectomy on gastric cancer: results of the Korean Gastric Cancer Study Group. World J Surg 1997;21:837-844. https://doi.org/10.1007/s002689900314
  100. Maehara Y, Moriguchi S, Yoshida M, Takahashi I, Korenaga D, Sugimachi K. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer 1991;67:3006-3009. https://doi.org/10.1002/1097-0142(19910615)67:12<3006::AID-CNCR2820671213>3.0.CO;2-V
  101. Meyer HJ, Jahne J, Wilke H, Pichlmayr R. Surgical treatment of gastric cancer: retrospective survey of 1,704 operated cases with special reference to total gastrectomy as the operation of choice. Semin Surg Oncol 1991;7:356-364. https://doi.org/10.1002/ssu.2980070607
  102. Otsuji E, Yamaguchi T, Sawai K, Ohara M, Takahashi T. End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric carcinoma. Surgery 1996;120:40-44. https://doi.org/10.1016/S0039-6060(96)80239-X
  103. Wanebo HJ, Kennedy BJ, Winchester DP, Stewart AK, Fremgen AM. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J Am Coll Surg 1997;185:177-184. https://doi.org/10.1016/S1072-7515(01)00901-2
  104. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 1995;19:532-536. https://doi.org/10.1007/BF00294714
  105. Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg 2006;93:559-563. https://doi.org/10.1002/bjs.5353
  106. Sano T, Yamamoto S, Sasako M. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF. Jpn J Clin Oncol 2002;32:363-364. https://doi.org/10.1093/jjco/hyf085
  107. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-730. https://doi.org/10.1056/NEJMoa010187
  108. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20 https://doi.org/10.1056/NEJMoa055531
  109. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007;357:1810-1820. https://doi.org/10.1056/NEJMoa072252
  110. Songun I, Keizer HJ, Hermans J, et al. Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG). Eur J Cancer 1999;35:558-562. https://doi.org/10.1016/S0959-8049(98)00429-8
  111. Miner TJ. Palliative surgery for advanced cancer: lessons learned in patient selection and outcome assessment. Am J Clin Oncol 2005;28:411-414. https://doi.org/10.1097/01.coc.0000158489.82482.2b
  112. Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJ. Value of palliative resection in gastric cancer. Br J Surg 2002;89:1438-1443. https://doi.org/10.1046/j.1365-2168.2002.02220.x
  113. Medina-Franco H, Contreras-Saldivar A, Ramos-De La Medina A, Palacios-Sanchez P, Cortes-Gonzalez R, Ugarte JA. Surgery for stage IV gastric cancer. Am J Surg 2004;187:543-546. https://doi.org/10.1016/j.amjsurg.2003.12.045
  114. Saidi RF, ReMine SG, Dudrick PS, Hanna NN. Is there a role for palliative gastrectomy in patients with stage IV gastric cancer? World J Surg 2006;30:21-27. https://doi.org/10.1007/s00268-005-0129-3
  115. Samarasam I, Chandran BS, Sitaram V, Perakath B, Nair A, Mathew G. Palliative gastrectomy in advanced gastric cancer: is it worthwhile? ANZ J Surg 2006;76:60-63. https://doi.org/10.1111/j.1445-2197.2006.03649.x
  116. Ouchi K, Sugawara T, Ono H, et al. Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 1998;69:41-44. https://doi.org/10.1002/(SICI)1096-9098(199809)69:1<41::AID-JSO8>3.0.CO;2-K
  117. Choi YB. Laparoscopic gatrojejunostomy for palliation of gastric outlet obstruction in unresectable gastric cancer. Surg Endosc 2002;16:1620-1626. https://doi.org/10.1007/s00464-002-0010-5
  118. Fiori E, Lamazza A, Volpino P, et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res 2004;24:269-271.
  119. Allum WH, Powell DJ, McConkey CC, Fielding JW. Gastric cancer: a 25-year review. Br J Surg 1989;76:535-540. https://doi.org/10.1002/bjs.1800760604
  120. Park DJ, Lee HJ, Kim HH, Yang HK, Lee KU, Choe KJ. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg 2005;92:1099-1102. https://doi.org/10.1002/bjs.4952
  121. Park CH, Song KY, Kim SN. Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea. Eur J Surg Oncol 2008;34:36-41. https://doi.org/10.1016/j.ejso.2007.03.004

Cited by

  1. Comparison of surgical methods and prognostic factors in T4 gastric cancer vol.9, pp.7, 2010, https://doi.org/10.1007/s10330-010-0619-0